4.5 Article

A methodological approach to studying resilience mechanisms: demonstration of utility in age and Alzheimer's disease-related brain pathology

期刊

BRAIN IMAGING AND BEHAVIOR
卷 13, 期 1, 页码 162-171

出版社

SPRINGER
DOI: 10.1007/s11682-018-9870-8

关键词

Resilience mechanisms; Homeodynamics; Methodological approach; Normal aging; Mild cognitive impairment; Alzheimer's disease

资金

  1. Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]
  2. DOD ADNI (Department of Defense) [W81XWH-12-2-0012]
  3. National Institute on Aging
  4. National Institute of Biomedical Imaging and Bioengineering
  5. Alzheimer's Association
  6. Alzheimer's Drug Discovery Foundation
  7. BioClinica, Inc.
  8. Biogen Idec Inc.
  9. Bristol-Myers Squibb Company
  10. Eisai Inc.
  11. Elan Pharmaceuticals, Inc.
  12. Eli Lilly and Company
  13. F. Hoffmann-La Roche Ltd.
  14. Genentech, Inc.
  15. GE Healthcare
  16. Innogenetics, N.V.
  17. IXICO Ltd.
  18. Janssen Alzheimer Immunotherapy Research & Development, LLC.
  19. Johnson & Johnson Pharmaceutical Research & Development LLC.
  20. Medpace, Inc.
  21. Merck Co., Inc.
  22. Meso Scale Diagnostics, LLC.
  23. NeuroRx Research
  24. Novartis Pharmaceuticals Corporation
  25. Pfizer Inc.
  26. Piramal Imaging
  27. Servier
  28. Synarc Inc.
  29. Takeda Pharmaceutical Company
  30. Canadian Institutes of Health Research

向作者/读者索取更多资源

The present work aims at providing a methodological approach for the investigation of resilience factors and mechanisms in normal aging, Alzheimer's disease (AD) and other neurodegenerative disorders. By expanding and re-conceptualizing traditional regression approaches, we propose an approach that not only aims at identifying potential resilience factors but also allows for a differentiation between general and dynamic resilience factors in terms of their association with pathology. Dynamic resilience factors are characterized by an increasing relevance with increasing levels of pathology, while the relevance of general resilience factors is independent of the amount of pathology. Utility of the approach is demonstrated in age and AD-related brain pathology by investigating widely accepted resilience factors, including education and brain volume. Moreover, the approach is used to test hippocampal volume as potential resilience factor. Education and brain volume could be identified as general resilience factors against age and AD-related pathology. Beyond that, analyses highlighted that hippocampal volume may not only be disease target but also serve as a potential resilience factor in age and AD-related pathology, particularly at higher levels of tau-pathology (i.e. dynamic resilience factor). Given its unspecific and superordinate nature the approach is suitable for the investigation of a wide range of potential resilience factors in normal aging, AD and other neurodegenerative disorders. Consequently, it may find a wide application and thereby promote the comparability between studies.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据